- Home
- NL vs NPCE Comparison
NL vs NPCE Comparison
Compare NL & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- NPCE
- Stock Information
- Founded
- NL 1891
- NPCE 1997
- Country
- NL United States
- NPCE United States
- Employees
- NL N/A
- NPCE N/A
- Industry
- NL Major Chemicals
- NPCE Medical Specialities
- Sector
- NL Industrials
- NPCE Health Care
- Exchange
- NL Nasdaq
- NPCE Nasdaq
- Market Cap
- NL 362.9M
- NPCE 424.1M
- IPO Year
- NL N/A
- NPCE 2021
- Fundamental
- Price
- NL $6.59
- NPCE $10.41
- Analyst Decision
- NL Sell
- NPCE Buy
- Analyst Count
- NL 1
- NPCE 7
- Target Price
- NL $6.00
- NPCE $15.14
- AVG Volume (30 Days)
- NL 37.3K
- NPCE 408.2K
- Earning Date
- NL 08-06-2025
- NPCE 08-12-2025
- Dividend Yield
- NL 5.49%
- NPCE N/A
- EPS Growth
- NL 441.25
- NPCE N/A
- EPS
- NL 1.25
- NPCE N/A
- Revenue
- NL $148,242,000.00
- NPCE $84,306,000.00
- Revenue This Year
- NL $15.75
- NPCE $21.00
- Revenue Next Year
- NL $2.44
- NPCE $11.81
- P/E Ratio
- NL $5.26
- NPCE N/A
- Revenue Growth
- NL N/A
- NPCE 22.05
- 52 Week Low
- NL $5.21
- NPCE $5.45
- 52 Week High
- NL $9.42
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- NL 35.16
- NPCE 31.48
- Support Level
- NL $6.69
- NPCE $12.63
- Resistance Level
- NL $7.19
- NPCE $13.91
- Average True Range (ATR)
- NL 0.35
- NPCE 0.76
- MACD
- NL -0.03
- NPCE -0.36
- Stochastic Oscillator
- NL 2.87
- NPCE 0.85
About NL NL Industries Inc.
NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.